Walter Flamenbaum, M.D. Chief Executive Officer
Prior to being appointed the Chief Executive Officer of AgenTus Therapeutics Walter Flamenbaum, M.D. has held a number of positions in healthcare. He is a board member of Stuart Pharmaceuticals since its inception in 2017. At present he is on the board of OSE Pharma, a French biotechnology company, and previously served on the board of BioMotiv, a US investment company. He has also been a board member of several US-based and international healthcare companies.